| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Freedman DX |
LSD, Psychotogenic Procedures, and Brain Neurohumors. |
Psychopharmacol Bull |
1975 |
| Johnson M, Hanson GR, Gib... |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... |
Eur J Pharmacol |
1989 |
| Olney JW, Labruyere J, Pr... |
Pathological changes induced in cerebrocortical neurons by phencyclidi... |
Science |
1989 |
| Walker FO, Hunt VP |
An open label trial of dextromethorphan in Huntington's disease |
Clin Neuropharmacol |
1989 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| Johnson M, Bush LG, Gibb ... |
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... |
Eur J Pharmacol |
1991 |
| Olney JW, Labruyere J, Wa... |
NMDA antagonist neurotoxicity: mechanism and prevention |
Science |
1991 |
| Farfel GM, Vosmer GL, Sei... |
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin ... |
Brain Res |
1992 |
| Nash JF, Yamamoto BK |
Methamphetamine neurotoxicity and striatal glutamate release: comparis... |
Brain Res |
1992 |
| Sosnowski M |
Pain management: physiopathology, future research and endpoints |
Support Care Cancer |
1993 |
| Finnegan KT, Calder L, Cl... |
Effects of L-type calcium channel antagonists on the serotonin-depleti... |
Brain Res |
1993 |
| Rossner S, Schliebs R, Bi... |
Ibotenic acid lesion of nucleus basalis magnocellularis differentially... |
Brain Res |
1994 |
| Farfel GM, Seiden LS |
Role of hypothermia in the mechanism of protection against serotonergi... |
J Pharmacol Exp Ther |
1995 |
| Williams A, Unwin R |
Prolonged elevation of serum creatine kinase (CK) without renal failur... |
Nephrol Dial Transpl... |
1997 |
| Fitzal S |
[Ketamine and neuroprotection. Clinical outlook] |
Anaesthesist |
1997 |
| Nikolajsen L, Hansen PO, ... |
Oral ketamine therapy in the treatment of postamputation stump pain |
Acta Anaesthesiol Sc... |
1997 |
| Nelson KA, Park KM, Robin... |
High-dose oral dextromethorphan versus placebo in painful diabetic neu... |
Neurology |
1997 |
| Pereira SP, McCarthy M, E... |
Auxiliary partial orthotopic liver transplantation for acute liver fai... |
J Hepatol |
1997 |
| Lindefors N, Barati S, O'... |
Differential effects of single and repeated ketamine administration on... |
Brain Res |
1997 |
| Colado MI, Granados R, O'... |
Role of hyperthermia in the protective action of clomethiazole against... |
Br J Pharmacol |
1998 |
| Jones HE, Li H, Balster R... |
Failure of ibogaine to produce phencyclidine-like discriminative stimu... |
Pharmacol Biochem Be... |
1998 |
| Plesan A, Hedman U, Xu XJ... |
Comparison of ketamine and dextromethorphan in potentiating the antino... |
Anesth Analg |
1998 |
| Shen M, Thayer SA |
Cannabinoid receptor agonists protect cultured rat hippocampal neurons... |
Mol Pharmacol |
1998 |
| de Bruin NM, Ellenbroek B... |
Differential effects of ketamine on gating of auditory evoked potentia... |
Psychopharmacology B... |
1999 |
| Kolesnikov YA, Pasternak ... |
Peripheral blockade of topical morphine tolerance by ketamine |
Eur J Pharmacol |
1999 |
| Arvanov VL, Liang X, Russ... |
LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... |
Eur J Neurosci |
1999 |
| Berman RM, Cappiello A, A... |
Antidepressant effects of ketamine in depressed patients |
Biol Psychiatry |
2000 |
| Weinbroum AA, Rudick V, P... |
The role of dextromethorphan in pain control |
Can J Anaesth |
2000 |
| Shirayama Y, Hashimoto K,... |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... |
Eur J Pharmacol |
2000 |
| Escher M, Desmeules J, Gi... |
Hepatitis associated with Kava, a herbal remedy for anxiety |
BMJ |
2001 |
| Kraft M, Spahn TW, Menzel... |
[Fulminant liver failure after administration of the herbal antidepres... |
Dtsch Med Wochenschr |
2001 |
| Russell BR, Laverty R |
The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-in... |
Pharmacology, Bioche... |
2001 |
| Reneman L, Majoie CBLM, S... |
Pre-frontal N-acetylaspartate is strongly associated with memory perfo... |
Biological Psychiatr... |
2001 |
| Colado MI, Camarero J, Me... |
A study of the mechanisms involved in the neurotoxic action of 3,4- me... |
Br J Pharmacol |
2001 |
| Vollenweider FX, Geyer MA |
A systems model of altered consciousness: integrating natural and drug... |
Brain Res Bull |
2001 |
| Krupitsky EM, Burakov AM,... |
Attenuation of ketamine effects by nimodipine pretreatment in recoveri... |
Neuropsychopharmacol... |
2001 |
| Vollenweider FX |
Brain mechanisms of hallucinogens and entactogens |
Dialogues Clin Neuro... |
2001 |
| Campo JV, McNabb J, Perel... |
Kava-induced fulminant hepatic failure |
J Am Acad Child Adol... |
2002 |
| Reneman L, Majoie CB, Fli... |
Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methyle... |
AJNR Am J Neuroradio... |
2002 |
| Smith KM, Larive LL, Roma... |
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... |
Am J Health Syst Pha... |
2002 |
| Gandolfi O, Gaggi R, Volt... |
The activation of serotonin receptors prevents glutamate-induced neuro... |
Pharmacol Res |
2002 |
| Umbricht D, Vollenweider ... |
Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Gene... |
Neuropsychopharmacol... |
2002 |
| Lim DK |
Ketamine associated psychedelic effects and dependence |
Singapore Med J |
2003 |
| Passie T, Karst M, Borsut... |
Effects of different subanaesthetic doses of (S)-ketamine on psychopat... |
J Psychopharmacol |
2003 |
| Dinse HR, Ragert P, Plege... |
Pharmacological modulation of perceptual learning and associated corti... |
Science |
2003 |
| Darlington CL |
Dexanabinol: A novel cannabinoid with neuroprotective properties |
IDrugs |
2003 |
| Moyano S, Frechilla D, De... |
NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... |
Psychopharmacology (... |
2004 |
| Daumann J, Fischermann T,... |
Proton magnetic resonance spectroscopy in ecstasy (MDMA) users |
Neurosci Lett |
2004 |
| Kukanich B, Papich MG |
Plasma profile and pharmacokinetics of dextromethorphan after intraven... |
J Vet Pharmacol Ther |
2004 |
| Chen SL, Huang EY, Chow L... |
Dextromethorphan differentially affects opioid antinociception in rats |
Br J Pharmacol |
2005 |
| Grasshoff C, Gillessen T,... |
Ketamine reduces cholinergic modulated GABA release from rat striatal ... |
Toxicol Lett |
2005 |
| Ostroff R, Gonzales M, Sa... |
Antidepressant Effect of Ketamine During ECT |
Am J Psychiatry |
2005 |
| Narendran R, Frankle WG, ... |
Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketam... |
Am J Psychiatry |
2005 |
| Tang Y, Zou H, Strong JA,... |
Paradoxical effects of very low dose MK-801 |
Eur J Pharmacol |
2006 |
| Zarate CA, Singh JB, Carl... |
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... |
Arch Gen Psychiatry |
2006 |
| de Win MM, Reneman L, Jag... |
A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Us... |
Neuropsychopharmacol... |
2006 |
| Carliss RD, Radovsky A, C... |
Oral administration of dextromethorphan does not produce neuronal vacu... |
Neurotoxicology |
2007 |
| Maeng S, Zarate CA, Du J,... |
Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... |
Biol Psychiatry |
2007 |
| Deakin JF, Lees J, McKie ... |
Glutamate and the neural basis of the subjective effects of ketamine: ... |
Arch Gen Psychiatry |
2008 |
| Stefanovic A, Brandner B,... |
Acute and chronic effects of ketamine on semantic priming: modeling sc... |
J Clin Psychopharmac... |
2009 |
| Dinis-Oliveira RJ, Carval... |
Suicide by hanging under the influence of ketamine and ethanol |
Forensic Sci Int |
2010 |
| Niciu MJ, Grunschel BD, C... |
Two cases of delayed-onset suicidal ideation, dysphoria and anxiety af... |
J Psychopharmacol |
2013 |
| Sanacora G, Smith MA, Pat... |
Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... |
Mol Psychiatry |
2013 |
| Benzer TI, Nejad SH, Floo... |
Case records of the Massachusetts General Hospital Case 40-2013A 36-ye... |
N Engl J Med |
2013 |
| Lally N, Nugent AC, Lucke... |
Anti-anhedonic effect of ketamine and its neural correlates in treatme... |
Transl Psychiatry |
2014 |
| McLaughlin G, Morris N, K... |
Test purchase, synthesis, and characterization of 2-methoxydiphenidine... |
Drug Test Anal |
2015 |
| Zorumski CF, Nagele P, Me... |
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... |
Front Psychiatry |
2015 |
| Litjens RP, Brunt TM |
How toxic is ibogaine? |
Clin Toxicol (Phila) |
2016 |
| Das RK, Tamman A, Nikolov... |
Nitrous oxide speeds the reduction of distressing intrusive memories i... |
Psychol Med |
2016 |
| Wallach J, Kang H, Colest... |
Pharmacological Investigations of the Dissociative 'Legal Highs' Diphe... |
PLoS One |
2016 |
| Kang H, Park P, Bortolott... |
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... |
Neuropharmacology |
2017 |
| Williams NR, Heifets BD, ... |
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor A... |
Am J Psychiatry |
2018 |
| Botanas CJ, de la Peņa JB... |
Methoxetamine: A foe or friend? |
Neurochem Int |
2019 |
| Martial C, Cassol H, Char... |
Neurochemical models of near-death experiences: a large-scale study ba... |
Conscious Cogn |
2019 |
| Zhang K, Hashimoto K |
Lack of Opioid System in the Antidepressant Actions of Ketamine |
Biol Psychiatry |
2019 |
